Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study (Q44785640)
Jump to navigation
Jump to search
scientific article published in May 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study |
scientific article published in May 2004 |
Statements
1 reference
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study (English)
1 reference
A Dmoszynska
1 reference
O Haus
1 reference
J Holowiecki
1 reference
S Giebel
1 reference
S Grosicki
1 reference
T Robak
1 reference
A Hellmann
1 reference
A Skotnicki
1 reference
L Konopka
1 reference
K Kuliczkowski
1 reference
K Zawilska
1 reference
M Komarnicki
1 reference
J Kloczko
1 reference
A Wierzbowska
1 reference
S Kyrcz-Krzemien
1 reference
W W Jedrzejczak
1 reference
B Stella-Holowiecka
1 reference
B Zdziarska
1 reference
B Marianska
1 reference
A Pluta
1 reference
K Sulek
1 reference
W Baran
1 reference
B Jakubas
1 reference
M Paluszewska
1 reference
M Kielbinski
1 reference
K Jagoda
1 reference
Polish Adult Leukemia Group (PALG)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference